Corium Reports First Quarter Fiscal 2016 Financial Results
February 08, 2016 16:03 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Positive Topline Results From Phase 1 PK Clinical Study of Once-Weekly Transdermal Corplex™ Donepezil as a Potential Treatment of Alzheimer’s Disease
February 03, 2016 16:03 ET
|
Corium International, Inc.
Demonstrates Sustained Delivery, Acceptable Skin Tolerability, and Pharmacokinetic Profile to Support the Feasibility of Once-Weekly Dosing Webcast and Conference Call Today at 5:00 p.m. ET (2:00...
Corium to Report First Quarter Fiscal Year 2016 Financial Results on Monday, February 8, 2016
February 01, 2016 16:03 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the first fiscal quarter ended December 31,...
Corium to Present at LEERINK Partners 5th Annual Global Healthcare Conference
January 26, 2016 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., Jan. 26, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Fourth Quarter and Fiscal Year 2015 Financial Results and Year-End Highlights
November 12, 2015 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report Fourth Quarter and Year-End Fiscal Year 2015 Financial Results on Thursday, November 12, 2015
November 05, 2015 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the fourth quarter and fiscal year (FY)...
Corium Announces Issuance of U.S. Patent for MicroCor(R) Transdermal System for a Broad Range of Therapeutics and Vaccines
August 26, 2015 10:15 ET
|
Corium International, Inc.
MENLO PARK, Calif., Aug. 26, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Initiates Phase 1 Clinical Trial of Corplex(TM) Donepezil Transdermal System for the Treatment of Alzheimer's Disease
August 25, 2015 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., Aug. 25, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Prices Follow-On Offering of Common Stock
August 05, 2015 20:26 ET
|
Corium International, Inc.
MENLO PARK, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Proposed Public Offering of Common Stock
August 03, 2015 16:01 ET
|
Corium International, Inc.
MENLO PARK, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...